We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.04%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$16.2B
AUM Growth
-$1.27B
(-7.2%)
Cap. Flow
-$1.42B
Cap. Flow
% of AUM
-8.75%
Top 10 Holdings %
Top 10 Hldgs %
18.5%
Holding
1,414
New
206
Increased
348
Reduced
372
Closed
450
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$456M |
| 2 |
Intel
INTC
|
+$290M |
| 3 |
Union Pacific
UNP
|
+$159M |
| 4 |
AT&T
T
|
+$143M |
| 5 |
Philip Morris
PM
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$394M |
| 2 |
AstraZeneca
AZN
|
+$307M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
TSMC
TSM
|
+$187M |
| 5 |
Canadian National Railway
CNI
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.82% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 9.75% |
| 4 | Industrials | 8.83% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZEP
826
DELISTED
ZEP INC COM STK (DE)
ZEP
| $526K | ﹤0.01% |
30,887
-4,071
| -12% | -$66.4K |
|
|
ZVO
827
DELISTED
Zovio Inc. Common Stock
ZVO
| $524K | ﹤0.01% |
54,318
+39,058
| +256% | +$393K |
|
|
ZIXI
828
DELISTED
Zix Corporation
ZIXI
| $521K | ﹤0.01% |
132,562
| – | – |
|
|
CHMT
829
DELISTED
Chemtura Corporation
CHMT
| $521K | ﹤0.01% |
+19,075
| New | +$471K |
|
830
Columbus McKinnon
CMCO
$556M
| $520K | ﹤0.01% |
19,320
| – | – |
|
|
BKMU
831
DELISTED
Bank Mutual Corp
BKMU
| $517K | ﹤0.01% |
70,631
-13,696
| -16% | -$95.7K |
|
|
ELNK
832
DELISTED
EarthLink Holdings Corp.
ELNK
| $511K | ﹤0.01% |
+115,100
| New | +$511K |
|
833
Texas Instruments
TXN
$257B
| $510K | ﹤0.01% |
+8,923
| New | +$501K |
|
|
ENLC
834
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $508K | ﹤0.01% |
+15,600
| New | +$517K |
|
835
Cimpress
CMPR
$2.29B
| $506K | ﹤0.01% |
+6,000
| New | +$479K |
|
836
First Financial Corp
THFF
$960M
| $504K | ﹤0.01% |
14,030
-4,806
| -26% | -$164K |
|
837
Ennis
EBF
$560M
| $503K | ﹤0.01% |
35,622
+18,481
| +108% | +$251K |
|
838
Clorox
CLX
$13B
| $497K | ﹤0.01% |
+4,500
| New | +$489K |
|
839
Tredegar Corp
TG
$284M
| $497K | ﹤0.01% |
24,725
-61,006
| -71% | -$1.28M |
|
840
Kadant
KAI
$3.91B
| $493K | ﹤0.01% |
9,370
| – | – |
|
841
Advanced Micro Devices
AMD
$775B
| $487K | ﹤0.01% |
181,575
-1,192,995
| -87% | -$3.35M |
|
842
Genesco
GCO
$431M
| $487K | ﹤0.01% |
6,834
-2,299
| -25% | -$167K |
|
|
CMRX
843
DELISTED
Chimerix, Inc.
CMRX
| $486K | ﹤0.01% |
+12,900
| New | +$512K |
|
844
Enova International
ENVA
$6.25B
| $483K | ﹤0.01% |
+24,505
| New | +$534K |
|
|
AYR
845
DELISTED
Aircastle Ltd
AYR
| $479K | ﹤0.01% |
21,307
+8,881
| +71% | +$193K |
|
|
FARO
846
DELISTED
Faro Technologies
FARO
| $473K | ﹤0.01% |
7,614
-15,055
| -66% | -$860K |
|
|
LTC
847
LTC Properties
LTC
$2.11B
| $472K | ﹤0.01% |
10,251
-29,713
| -74% | -$1.34M |
|
|
GTY
848
Getty Realty Corp
GTY
$2.02B
| $465K | ﹤0.01% |
25,847
-23,778
| -48% | -$430K |
|
849
KLA
KLAC
$252B
| $460K | ﹤0.01% |
+79,000
| New | +$506K |
|
|
WP
850
DELISTED
Worldpay, Inc.
WP
| $460K | ﹤0.01% |
+12,200
| New | +$441K |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2015 Portfolio in Review
As of Q1 2015, Arrowstreet Capital held 1,414 positions worth $16.2B, down 7.2% from $17.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $1.42B in Q1 2015, closing 450 positions and reducing 372 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $394M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Arrowstreet Capital opened a new position in Apple worth $470M.
- Arrowstreet Capital's largest Q1 2015 buy was Apple: 15,110,160 shares worth $470M.
- Arrowstreet Capital added most to Intel in Q1 2015, an estimated $290M increase.
- Arrowstreet Capital's biggest Q1 2015 reduction was AstraZeneca, cutting an estimated $307M.
- Arrowstreet Capital fully exited Teva Pharmaceuticals in Q1 2015, selling an estimated $394M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $16.2B portfolio in Q1 2015.
- Arrowstreet Capital opened 206 new positions and closed 450 in Q1 2015.
- Arrowstreet Capital's portfolio value fell 7.2% quarter-over-quarter to $16.2B.
Based on Arrowstreet Capital's 13F filing for Q1 2015, filed 15 May 2015.